AGIO:NASDAQ
Agios Pharmaceuticals Inc
31,59 USD
arrow_downward
-0,54%(-0,17) 1D
13-ноя., 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
31,64 USD
High
31,97 USD
Low
30,81 USD
Mkt. cap
1,89 млд
Avg. vol.
1,25 млн
Volume
371,34 миң
52-wk high
45,99 USD
52-wk low
22,24 USD
EPS
-6,32 USD
Beta
0,66
Shares outstanding
59,81 млн
No. of employees
540
Open
31,64 USD
High
31,97 USD
Low
30,81 USD
Mkt. cap
1,89 млд
Avg. vol.
1,25 млн
Volume
371,34 миң
52-wk high
45,99 USD
52-wk low
22,24 USD
EPS
-6,32 USD
Beta
0,66
Shares outstanding
59,81 млн
No. of employees
540
News stories
From web sources and news partners
BigGo Finance
·
5 саат мурун
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
The Motley Fool
·
4 саат мурун
Tesla Is Down 13% in 2026 While the S&P 500 Is Up. Here’s the 1 Catalyst Left This Year That Could Flip That.
24/7 Wall St.
·
2 саат мурун
Gilead Beat the S&P 500 by More Than 25 Points in the Past Year, but $1,000 From a Decade Ago Is Still Worth Less Than $3,500
Traders Union
·
2 саат мурун
Chris Ciovacco: Semiconductors SMH and S&P 500 SPY show several possible support areas
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc